Uncialis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,252,591 | 1,698,040 | 979,570 | 1,181,232 | 1,092,434 | 1,244,066 | 846,730 | 138,140 |
| Profit before tax | 63,193 | 82,569 | 25,899 | 57,575 | 17,924 | 9,078 | 16,487 | -8,085 |
| Net profit | 57,457 | 72,308 | 19,501 | 50,367 | 13,184 | 5,977 | 13,758 | -8,133 |
| Equity | 87,403 | 99,711 | 119,212 | 169,579 | 182,763 | 188,740 | 202,498 | 194,365 |
| Liabilities | 81,947 | 56,359 | 37,500 | 33,783 | 38,422 | 90,858 | 51,615 | 45,663 |
| Non-current assets | 2,010 | 1,045 | 81 | 15,000 | 12,353 | 9,706 | 7,059 | 0 |
| Current assets | 167,252 | 154,956 | 156,558 | 187,597 | 208,060 | 269,014 | 246,766 | 239,928 |
| Total assets | 169,262 | 156,001 | 156,639 | 202,597 | 220,413 | 278,720 | 253,825 | 239,928 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 15,259 | 26,017 | 1,387 |
| Social insurance contributions | - | - | - | - | - | 2,476 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +42.2% | +35.6% | -42.3% | +20.6% | -7.5% | +13.9% | -31.9% | -83.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 33.9% | 46.4% | 12.4% | 24.9% | 6.0% | 2.1% | 5.4% | -3.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 65.7% | 72.5% | 16.4% | 29.7% | 7.2% | 3.2% | 6.8% | -4.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.6% | 4.3% | 2.0% | 4.3% | 1.2% | 0.5% | 1.6% | -5.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.0% | 4.9% | 2.6% | 4.9% | 1.6% | 0.7% | 1.9% | -5.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.6 | 0.3 | 0.2 | 0.2 | 0.5 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 385,413 | 566,013 | 317,702 | 329,649 | 273,109 | 364,113 | 282,243 | 57,161 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Uncialis - Social security debts
The amount of overdue SODRA debt for the company Uncialis as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-10 | 2026-09-14 | 0.01 |
| 2026-07-23 | 2026-07-26 | 0.01 |
| 2026-04-20 | 2026-04-21 | 5.29 |
| 2026-03-19 | 2026-03-22 | 8.44 |
| 2025-10-23 | 2025-11-10 | 6.95 |
| 2025-09-18 | 2025-09-29 | 86.83 |
| 2025-09-16 | 2025-09-17 | 537.52 |
| 2025-09-07 | 2025-09-15 | 529.08 |
| 2025-08-31 | 2025-09-03 | 529.08 |
| 2025-08-19 | 2025-08-29 | 529.08 |
| 2025-07-24 | 2025-07-31 | 534.38 |
| 2025-07-16 | 2025-07-23 | 529.08 |
| 2025-06-17 | 2025-06-26 | 753.13 |
| 2025-04-30 | 2025-04-30 | 757.60 |
| 2025-04-16 | 2025-04-28 | 757.60 |
| 2022-10-28 | 2022-11-02 | 0.03 |
| 2022-04-28 | 2022-05-01 | 0.04 |
| 2022-02-17 | 2022-02-22 | 18.72 |
Uncialis - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Uncialis is: 208 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 208.23 |
| 2026-08-28 | 2026-08-31 | 207.87 |
| 2026-05-30 | 2026-06-04 | 46.87 |
| 2026-03-11 | 2026-03-17 | 1930.0 |
| 2026-01-27 | 2026-03-10 | 16.36 |
| 2026-01-18 | 2026-01-26 | 14.88 |
| 2026-01-17 | 2026-01-17 | 56.69 |
| 2026-01-13 | 2026-01-16 | 1499.65 |
| 2026-01-11 | 2026-01-12 | 1498.54 |
| 2026-01-01 | 2026-01-10 | 1488.25 |
| 2025-12-31 | 2025-12-31 | 1480.11 |
| 2025-12-19 | 2025-12-30 | 1480.67 |
| 2025-12-10 | 2025-12-18 | 1738.67 |
| 2025-12-01 | 2025-12-09 | 1731.23 |
| 2025-11-27 | 2025-11-30 | 1729.03 |
| 2025-11-25 | 2025-11-26 | 1729.28 |
| 2025-11-14 | 2025-11-24 | 1824.11 |
| 2025-11-09 | 2025-11-13 | 1821.29 |
| 2025-11-08 | 2025-11-08 | 1818.0 |
| 2025-11-02 | 2025-11-07 | 1811.04 |
| 2025-10-24 | 2025-11-01 | 1807.23 |
| 2025-10-23 | 2025-10-23 | 1892.23 |
| 2025-10-15 | 2025-10-22 | 1888.31 |
| 2025-10-05 | 2025-10-14 | 1882.92 |
| 2025-10-02 | 2025-10-04 | 1881.45 |
| 2025-09-28 | 2025-10-01 | 1879.49 |
| 2025-05-24 | 2025-05-24 | 215.87 |
| 2025-05-17 | 2025-05-23 | 215.92 |
| 2025-04-28 | 2025-04-28 | 187.72 |
| 2025-04-16 | 2025-04-27 | 1.72 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Uncialis, UAB (code 151433517) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €138.1K and recorded a net loss of €8.1K, corresponding to a negative profit margin of 5.9%. Revenue declined sharply compared with 2024, when turnover was €846.7K and net profit reached €13.8K, and it was also well below the 2023 level of €1.24M, when net profit was €6.0K. This shows a clear downward multi-year trend in sales and a deterioration in profitability. At the end of 2025, total assets stood at €239.9K, equity at €194.4K and liabilities at €45.7K. The equity ratio was 81.0% and debt-to-equity 0.23, indicating a relatively low leverage position. Return on equity was -4.2% and return on assets -3.4%, while asset turnover was 0.58x. Revenue per employee was €69.1K, and profit per employee was -€4.1K.